技术辅助感觉运动功能评估:不同利益相关者的使用现状、障碍与未来方向
受访者包括临床医生、研究工程师、基础科学家、医疗行业人员等。总体共识包括评估原因和未来方向,但在评估频率和 adoption 障碍上存在分歧。缺乏时间、成本、标准化不足及理解/可解释性差是主要障碍,报销和标准化被视为未来优先事项。
要点
- 多数受访者有技术辅助评估经验,但临床采用仍有限。
- 主要障碍为缺乏时间、成本、标准化不足及可解释性差。
- 报销和标准化是推动该领域发展的前两项优先活动。
核心结论
- 技术辅助感觉运动评估亟需标准化,并需配合跨学科活动、教育和科学语言对齐以促进临床使用。
主要发现
- 67%的受访者在职业中拥有超过5年康复经验,97%接触过技术辅助评估。
- 临床医生认为成本是 adoption 的首要障碍,而研究工程师指出设备相关因素和缺乏标准化。
- 总体主要障碍为缺乏时间、成本、缺乏标准化以及理解/可解释性差。
- 报销和标准化被列为未来几年推动技术辅助感觉运动评估领域的首要两项活动。
临床怎么用
- 临床引入技术辅助评估时需优先考虑成本、时间、标准化和结果可解释性。
- 推动报销和标准化建设是促进技术辅助评估临床落地的关键方向。
局限性
- 原始摘要未报告局限性信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is growing interest in the use of technology in neurorehabilitation, from robotic to sensor-based devices. These technologies are believed to be excellent tools for quantitative assessment of sensorimotor ability, addressing the shortcomings of traditional clinical assessments. However, clinical adoption of technology-based assessments is very limited. To understand this apparent contradiction, we sought to gather the points-of-view of different stakeholders in the development and use of technology-aided sensorimotor assessments. METHODS: A questionnaire regarding motivators, barriers, and the future of technology-aided assessments was prepared and disseminated online. To promote discussion, we present an initial analysis of the dataset; raw responses are provided to the community as Supplementary Material. Average responses within stakeholder groups were compared across groups. Additional questions about respondent's demographics and professional practice were used to obtain a view of the current landscape of sensorimotor assessments and interactions between different stakeholders. RESULTS: One hundred forty respondents from 23 countries completed the survey. Respondents were a mix of Clinicians (27%), Research Engineers (34%), Basic Scientists (15%), Medical Industry professionals (16%), Patients (2%) and Others (6%). Most respondents were experienced in rehabilitation within their professions (67% with > 5 years of experience), and had exposure to technology-aided assessments (97% of respondents). In general, stakeholders agreed on reasons for performing assessments, level of details required, current bottlenecks, and future directions. However, there were disagreements between and within stakeholders in aspects such as frequency of assessments, and important factors hindering adoption of technology-aided assessments, e.g., Clinicians' top factor was cost, while Research Engineers indicated device-dependent factors and lack of standardization. Overall, lack of time, cost, lack of standardization and poor understanding/lack of interpretability were the major factors hindering the adoption of technology-aided assessments in clinical practice. Reimbursement and standardization of technology-aided assessments were rated as the top two activities to pursue in the coming years to promote the field of technology-aided sensorimotor assessments. CONCLUSIONS: There is an urgent need for standardization in technology-aided assessments. These efforts should be accompanied by quality cross-disciplinary activities, education and alignment of scientific language, to more effectively promote the clinical use of assessment technologies. TRIAL REGISTRATION: NA; see Declarations section.
引用
- Shirota C, Balasubramanian S, Melendez-Calderon A, et al. Technology-aided assessments of sensorimotor function: current use, barriers and future directions in the view of different stakeholders. J Neuroeng Rehabil. 2019. PMID: 31036003. doi:10.1186/s12984-019-0519-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。